E83.119

Hemochromatosis, unspecified

Risk-adjusting (HCC)Billable code

HCC risk adjustment mapping

RxHCC V08

RXHCC43

Pituitary, Adrenal Gland, and Other Endocrine and Metabolic Disorders

Coding notes

Excludes 1 never coded together · Excludes 2 may co-exist

Inherited from E83.11Hemochromatosis
Excludes 1

GALD (P78.84) Gestational alloimmune liver disease (P78.84) Neonatal hemochromatosis (P78.84)

Inherited from E83.1Disorders of iron metabolism
Excludes 1

iron deficiency anemia (D50.-) sideroblastic anemia (D64.0-D64.3)

Inherited from E83Disorders of mineral metabolism
Excludes 1

dietary mineral deficiency (E58-E61) parathyroid disorders (E20-E21) vitamin D deficiency (E55.-)

Inherited from E70-E88Metabolic disorders
Excludes 1

androgen insensitivity syndrome (E34.5-) congenital adrenal hyperplasia (E25.0) hemolytic anemias attributable to enzyme disorders (D55.-) Marfan syndrome (Q87.4-) 5-alpha-reductase deficiency (E29.1)

Excludes 2

Ehlers-Danlos syndromes (Q79.6-)

Inherited from chapter 4Endocrine, nutritional and metabolic diseases
Excludes 1

transitory endocrine and metabolic disorders specific to newborn (P70-P74)

Note

All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.

Official Guidelines for E83.119

FY 2026 ›

Find E83.119 in the alphabetic index

1 index path leads to this code